These findings suggest that patients with suspected ALPS might be classified with ALPS-U or had pathogenic variants in the deep intronic regions/UTR regions in FAS, FADD, FASLG, or CASP10, which were not covered/detected in this genetic test. The gene discussed is FASLG; the disease is autoimmune lymphoproliferative syndrome.